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Abstract We characterized genes for prophenin (PF)-2 and PR- 
39, two cathelin-associated antimicrobial peptides found in por- 
cine leukocytes. Both contained 4 exons and 3 introns and were 
compact, contiguous and highly homologous. Exons I-III en- 
coded most of their cathelin domains. Exon IV specified the final 
few cathelin residues, including its conserved C-terminal valine, 
followed by the mature PR-39 peptide or a PF-2 precursor. The 
highly conserved 5' flanking sequences of this gene family con- 
tained NF-~cB, IL-6, GM-CSF and NF-! binding motifs and the 
introns were unusually conserved. These data suggest that the 
panoply of porcine cathelin-associated antimicrobial peptides 
arose relatively recently via gene reduplications and exon shuf- 
fling, and that in vivo expression of cathelin-associated antimicro- 
bial peptides may respond to mediators generated early during 
infection. 
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1. Introduction 
Endogenous antimicrobial peptides produced by leukocytes 
are fundamental contributors to innate immunity against mi- 
crobial infections [1]. Recent cDNA cloning studies have re- 
vealed that many structurally and functionally diverse leuko- 
cyte antimicrobial peptides hare a highly conserved pro-re- 
gion, known as the 'cathelin' domain. Among these are bovine 
indolicidin, cyclic dodecapeptide, Bac 5 and Bac 7 [2 7]; rabbit 
'P15' and CAP 18 [8-11]; porcine PR-39 [12,13], protegrins 
[14-16], prophenins [17-19], PMAP-23, PMAP-36 and PMAP- 
37 [20-22]; and human FALL-39/CAP-18 [23,24]. 
Several cathelin-associated antimicrobial peptides, including 
porcine PR-39 [12], protegrins PGI-3 [14], and prophenin [17], 
have been isolated from leukocytes. Others, including porcine 
PMAP-23, PMAP-36, PMAP-37 and protegrins PG-4 and 5 
have been synthesized based on their cDNA or gene sequences. 
In some cases, both peptide isolation and cDNA cloning have 
been accomplished. For example, Pungercar et al. obtained two 
cDNA clones from porcine bone marrow, 'clone-12' and 'clone- 
6', that encoded nearly identical proline-rich antimicrobial pep- 
tides [18,19] and we independently purified the corresponding 
mature peptides, Prophenin (PF)-I and 2, from porcine leuko- 
cytes [17]. 
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Sequence data have been deposited with EMBL/GenBank Libraries 
with the following accession numbers X89201 S. scrofa flPR-39 gene, 
X89202 S. scrofa PF-2 gene 
To date, only genes for porcine protegrins and PR-39 have 
been described [25,26]. We now report the structures of genes 
for prophenin-2 (PF-2) and a variant form of PR-39. 
2. Materials and methods 
2.1. Genomic screening and Southern blot analysis 
A porcine liver genomic library in EMBL3 SP6/T7 (Clontech, Palo 
Alto, CA) was screened as previously described [25]. Genomic DNA 
was purified from hybridizing clones, digested with various restriction 
endonucleases (New England Biolabs, Beverly, MA) and resolved by 
electrophoresis in 0.8% agarose gels. Overnight capillary transfer to 
Gene Screen Plus membranes (Dupont, Boston, MA) was followed by 
prehybridization in a Rap-hyb buffer with 100 pg/ml of denatured 
salmon sperm DNA. Subsequently, the filters were hybridized for 2 h 
at 60°C with radio-labeled cDNA or at 42°C with radiolabelled syn- 
thetic oligonucleotides. The final wash was performed in0.1 x SSC with 
0.1% SDS, at either 60°C or 42°C, respectively. 
2.2. Polymerase chain reaction ( PCR) 
Oligonucleotide primers derived from PF-2 (clone-12), PR-39, and 
protegrin cDNA sequences [13,15,16,18] were used (Table 1). Reactions 
were carried out in a total volume of 50 ,ul containing 50 ng of selected 
genomic library DNA (templates), 25pl of each primer, 1 pl of 10 mM 
dNTP, 5/11 of 10 × PCR buffer (200 mM Tris-HCl, 100 mM (NH4)2, 
20 mM MgSO 4, 1% Triton X-100, 0.1% BSA), and 2.5 units of cloned 
pfu DNA polymerase (Stratagene, La Jolla, CA) overlaid with 20/11 
'Chill-out' liquid wax. Thirty cycles were performed, as follows: 1 min 
denaturation at94°C, 1 min primer annealing at 55°C, 2 min primer 
extension at 72°C and 10 rain final extension at 72°C. 
2.3. Gene cloning and sequencing 
PCR DNA products of interest and restriction fragments ofgenomic 
library clones were fractionated byagarose gel electrophoresis, excised, 
purified with a QIAEX Gel Extraction kit (QIAGEN Inc, Chatsworth, 
CA), and ligated into pBluescript KS+ vector or pCR-Script SK+ 
cloning vector. DNA for sequencing was prepared with a QIAGEN 
plasmid kit, and sequenced bythe dideoxynncleotide chain termination 
method using a Sequenase v rsion 2.0 kit (U.S. Biochemical, Cleveland, 
OH), and/or a Bst DNA sequencing kit (Bio-Rad Laboratories, Mel- 
ville, NY), and pBluescript universal primers, or specific primers based 
on PF, and PR-39 cDNA sequences. DNA sequences were analyzed 
using PC-Gene (Intelligenetics, Palo Alto, CA). 
3. Results and discussion 
By screening a pig genomic library of ~ 2.3 × 105 clones with 
protegrin (PG) cDNA that contained the conserved cathelin 
region, we identified 45 hybridizing clones [25]. About half of 
these did not hybridize with our protegrin-specific oligonucleo- 
tide probe, P4 (Table 1), indicating that they contained non- 
protegrin, cathelin-associated genes. Ten P4-negative clones 
were digested with restriction enzymes. Three of these (Fig. 1) 
hybridized with oligonucleotide probe-P5, which was specific 
for prophenin, and one of these (Clone-13) also hybridized with 
probes-P7 (Fig. 1 ) and P6 (data not shown), which were specific 
for PR-39. 
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Fig. 1. Southern blot analysis of prophenin (PF) and PR-39 genes. 
Three PF-positive genomic lones were digested with PstI, fractionated 
on agarose gels and transferred tonylon membranes. The membranes 
were first hybridized with the prophenin (PF)-specific probe-P5, then 
washed and re-probed with the PR-39 specific probe-P7. 
Fig. 1 also indicates that clone 2 contained at least two PF 
genes, and that clone 13 contained at least one PF gene and one 
PR-39 gene. We also hybridized 15 PG containing clones with 
probe-P5 (PF specific) and probe-P7 (PR-39 specific). Al- 
though no PF-hybridizing clone was found, 1 of these clones 
reacted with the PR-39 probe, indicating that PR-39 and prote- 
grin genes are contiguous (data not shown). 
PCR amplification of clones 1, 2 and 13 was done with 
different primer pairs (Fig. 2) and the 7 PCR products were 
Table 1 
Oligonucleotides for PCR and southern blot studies 
subcloned into pBluescript vector and sequenced. Products 1 
and 2 contained the PF-2 coding region; product 3 contained 
the coding region of a novel PR-39 gene which we called flPR- 
39. Products 4-6 encoded the mature PF-2 peptide and its 
Y-untranslated region; product 9 coded for the mature PR-39 
peptide and its 3'-untranslated region (confirming that clone 13 
contained both PF-2 and flPR-39 genes). To obtain the 5'- 
flanking region of the PF-2 gene, clone 1 DNA was cut with 
PstI, and probed with the oligonucleotide P8 (Table 1). A 
hybridizing 1.2 kb fragment was identified, inserted into 
pBluescript KS vector and sequenced. It comprised 691 bp of 
the 5'-flanking region, exon I and most of intron I of the PF-2 
gene. To obtain the Y-flanking region of flPR-39 gene, PCR 
amplification of our clone 13 DNA was done with primers P9 
and P10 (Table 1). The 1.1 kb PCR product was inserted into 
pBluescript vector and sequenced, revealing that it contained 
the 5'-flanking region (142 bp) exon I, intron I, exon II, intron 
II and exon lI I of the flPR-39 gene. 
The genes for PF-2 andflPR-39 both consisted of four exons 
and three introns (Figs. 3 and 4, Table 2). A very short 5'- 
untranslated segment was contained in Exon I, along with the 
codons of the first 66 amino acids, including a 29 residue signal 
peptide and the first 37 cathelin residues. Exons II and III 
contained the next 60 cathelin residues. Exon IV contained the 
final 2 or 4 cathelin residues and the complete sequences of 
mature PF-2 or flPR-39, followed by their Y-untranslated re- 
gions and polyadenylation sites, respectively. Both the cDNA 
(18 and unpublished ata) and gene structures (Fig. 4) of PF-2 
indicate that its post-cathelin portion of PF-2 should begin 
from the seventh bp in exon IV. However, when mature PF-I 
purified from pig leukocytes, it lacked the predicted 18 residue 
N-terminal segment and the C-terminal Gly-Arg-Arg sequence, 
which had evidently been removed during post-translational 
processing [17]. 
The amino acid sequence corresponding to our PF-2 gene 
was identical to that deduced previously from the cDNA of 
Pungercar's clone-12 [18]. The flPR39 genomic clone was al- 
most identical to the cDNA sequence of PR-39 reported by 
Storici and Zanetti [13], differing principally by a base pair and 
codon change (GCA to GGA) in Exon 1. This would cause a 
Gly 2~ for Ala 2~ substitution in the signal sequence, without 
altering the mature PR-39 peptide. The cathelin domain en- 
coded by our flPR-39 gene corresponded precisely to the cathe- 
lin sequence reported by Storici and Zanetti [13]. In contrast, 
the PR-39 gene recently reported by Gudmundson et al. [26] 
Primers Sequences (5'-3') cDNA Location references 
Pl GTCGGAATT CATGGAGACCCAGAGG t o r AI GCCAG S** 1 -20(+)*  [15] 
P2 GTCGTCTAGAC (or G) GTTTCACAAGAATTTATTT  S 672-691 (-) * [15] 
P3 ATGGGCTCACCTGGGCACC PR- 39 1 - 17 ( + ) [ 13 ] 
P4 GCAGAACCTACGCCTACAATAGCACAG PG 403-429 (-) [15] 
P5 CT CAAGCTTGTCAGGAGATTT CCCTGGTGG PF 384-404 (+) [18] 
P6 GTCGGAATTCAGGAGACGTCCCCGAC PR-39  408-423 (+) [13] 
P7 C CAAGG C T C C CAC CAAGGATCAT PR-39  465-485 (+) [13] 
P8 CACCACGAGTC (orG) CCAGCAGCAGAAG S 49-72  ( - ) [15] 
P9 CTCATTACAGGAGATGTCCAG PR-39  375-395 (-) [13] 
PI0 CCCACTGCGCAGCAATCCCCTGA PR-39  gene  686-708 (+) [26] 
*(+) and (-) indicate positive and negative strands, respectively. **S indicates that the sequences ofPF, PR-39 and PG are identical. 
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Fig. 2. PCR amplification ofprophenin and PR-39 genes. PCR prod- 
ucts obtained using a clone 1 template are shown in lanes 1, 4 and 7. 
PCR products from a clone 2 template are shown in lanes 2, 5 and 8. 
PCR products from a clone 13 template are in lanes 3, 6 and 9. Primer 
(P) pairs, as described inTable 2, were used as follows: lanes 1, 2: PI 
& P2, lane 3:P3 & P2; lanes 4, 5, 6:P5 &/P2; lanes 7, 8, 9:P6 & P2. 
differed from Storici and Zanetti's cDNA by 7 base pair 
changes (and 5 amino acid substitutions) in the cathelin domain 
segments encoded within Exons II and III. 
We scanned the 5'-flanking region of PF-2 for eukaryotic 
promoter elements. Fig. 4 shows the consensus TATA-like box 
(ATAAA) identified in the region of -32 to -28. The sequence 
differs from the consensus TATA(TA)A by first base deletion, 
but it meets the -30 location requirement. Other potential 
regulatory motifs shown in Fig. 4 include sites for NF-xb, 
NF-IL6, IL-6RE, GMCSF and NFI. Corresponding sites were 
present in the previously reported protegrin and PR-39 genes 
[25,26]. The 142 bps sequenced in the 5'-region of the flPR39 
gene were identical to their counterparts in PF-2 and PG genes. 
Genes encoding PF-2 and flPR-39 had identical layouts, with 
four exons and three introns (Fig. 3). The sequences ncoding 
the mature peptides were located in exon IV, which began with 
the final 2 or 4 residues fo the cathelin domain. Table 2 show 
the resemblance of PF-2 and flPR-39 genes to each other and 
to protegrin genes. From the PstI cut site in its 5'-flanking 
region to the end of intron III, only 17 nucleotide substitu- 
tions, 1 nucleotide deletion and a 6 bp difference in the 
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Fig. 3. Structures of prophenin PF-2, flPR-39, and protegrin (PG) 
genes. Open boxes denote the four exons (E). The extreme l ft portion 
(shaded) of exon I (El) denotes the 5'-untranslated region, and the 
black box in exon 4 (E4) represents the sequences ncoding the mature 
peptides. The restriction sites are PstI (P), EcoRI (E), HindIII (H). The 
map is drawn to scale. 
length of intron III distinguished the PF-2 and protegrin 
genes. 
The present studies, in conjunction with recent descriptions 
of protegrin [25] and PR-39 [26] genes provide a coherent pic- 
ture of the porcine genes that encode cathelin-associated anti- 
microbial peptides. All of them have identical structures that 
differ substantially from those of defensin genes [27,28]. Their 
homology and nearby chromosomal locations uggests that the 
remarkably large family of cathelin-containing antimicrobial 
peptides expanded via gene reduplication and insertion or sub- 
stitution of novel sequences into exon IV of previous family 
members. The conserved intron sequences of the genes could 
reflect: (a) the recency of this expansion; (b) the occurrence of 
specific gene conversion events that assured overall sequence 
preservation; (c)evolutionary selection occasioned by the func- 
tional significance of the intron sequences; or (d) combinations 
of the aforementioned possibilities. Intron I of the Ha-ras genes 
of humans and rodents is highly conserved and contains at least 
3 cis-acting regulatory elements that modulate gene expression 
[29]. Regulatory elements also exist in intron II of the KI-ras 
gene [30]. 
Since one of our cloned 15 21 kb inserts contained both PF 
and PR-39 genes and another contained both PG and PR-39 
genes, it is apparent that the multiple PG, PR-39, and PF are 
densely clustered, presumably on porcine chromosome 13 [26]. 
Our flPR-39 gene and the PR-39 gene recently described by 
Gudmundsson et al. [26] differed on average by 3.6%, reflecting 
occasional base pair substitutions scattered throughout the 
gene. 
Table 2 
Homology of PF-2, flPR-39 and PG-I genes 
Gene base pairs 5' side Exonl IntronI ExonII IntronII ExonIII IntronIII ExonlV 
PF-2 691 211 404 108 152 72 601 424 
PG-1 690 211 404 108 152 72 595 313 
flPR-39 142 215"* 404 108 !46 72 591 263 
Comparisons Homology of the gene sequences (%identity) 
PG-1/PF-2 99.0 100 99.8 99.1 98.0 100 99.0 85.3* 
flPR39/PG-1 99.3 99.5 99.5 99.1 86.8 76.4 69.4* 58.1" 
*Gaps (/> 10 base pair deletions) were omitted from the calculation. **This difference between flPR-39 and PF-2 or PG-I reflects an alternative 
transcriptional start site. 
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c t gcagt  ggcc  tggag  t g t  gagacggat  agaaagagt  tggcgt  cacagcat  agccg& c c t -632 
ttcctcatacttggtagggaagsSgccggggaacaggtcatgtccagg~saacgtgggga -572 
t 9ggf fea  t t t t t agact  gagagagcagt  caagaaaagegeaggagaggagac  cagggagc  -512  
Gscs 
tgaccctatatcataggtagtgtggtgttgactatcaactaggaactggcgggtctgtaa -452 
gactctggtttgtgttggtactatcatccctccattacactttaatttagggcttcctag -392  
oscsF  
gt  gc  caggcagcacc  t agagctggggacagag tgc tgactaca  c t cc tggaccctggt  t c -332 
ctgaggcggccaac  c t ggggac  ccagag caggt  g tgagacagt  Scc tgcct  c t  cc t  tc t  c -272  
ctgaaggacccaac  cc t  c t t gagcaac  cc t  gcc tgt  gacact  gcc tgt  ~ggg cccaggag 212 
aggccaggacactgtcagggcgatggagaaaccact  tc t  t cacc t  tgcacaggcgcccgt  - 152 
. . . . . . . .  g . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  
ccttccccactgcccagcaatcccctua~caaoagccagg~ctoauucaaotccagcca - 92 
gcatcctua~aaucaaccagggatggggccgctcaa~aagtc=cagacccaggctg~gcl -32 
TAT A ~L6RE M E T Q.~ 5 
CCAGCCTGTGCCTGGGGCGCTGGTCACTGTGGCTTCTGCTGCTGGCACTCGTGGTGCCCT 89  
A S L C L G K ~ S L W L L L L A I, V V ~ 25 
CGG C CAGC GCC CAGGCC CTCAGCTACAGGGAGGC CGTGCTTCGTGCq~TGGAT CGC C TCA 149  
S A S A Q A L S Y R E A V L R A V D R L 49 
AC GAGCAGTCCTCGGAAG CTAATCTCTAC CGCCTCCTGGAGCTGGAC CAGC C GC C CAAGG 209 
N E Q S S E A N L Y R L L E L D ~ P P K 65 
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  C 
CC@t  gag  t cg~gcaggggc  t caggaggggc  t ggggggcgggggct  g t  c =c  c c acccgcct  269  
A 86 
CgSggctccctgtccc~ccccctgctcaggctgtccctcctgccaggaaggcacttgtcc 329 
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  g-. -  
ct  c taagggggaccccct  c tgccaggaaacct  t cccagagctgggtsccc tgcccgcstg  389  
agagcttcccgccttagcctctgggctgt~ggctcaggsccctgcacagcctgtgaggca 449 
ggagcgggct  c tg tcccc t  cccc tgtgcacccagcaccaagcccagggccaggct  cccag  5O9 
. . . . . . . . . . . . . . . . . . . . .  c . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  
caggggctgcagaggctgctgtctaggtgggggcggggag~Sgg~gacagatccgagggg 569 
saagcctgagcccgagtcc~atctccccactttgatccttgaccagGACGAGGACCCGGG 629 
D E D P G 71  
tACCCCGAAACCTGTGAGCTTCACGGTGAAGGAGACTGTGTGTCCCAGGCCGACCCGGCG 689 
T P K P V S F T V K E T V C P R P T R R 91  
~CCCCCGGAGCTGTGTGACTTCAAGGAGAACGGGgt  gaggct  gggggc  tgggggcgctgg  749  
P P E L C D F K E N G i0~ 
. . . . . . . . . . . . . . . . . . . . . . . .  g . . t . - . . - . t  . . . . . . . . . . . . . . . . . . . . . .  t . .  
cggatgcttcccaaggagct~aacaggagagcctgctg~ggaagatgtccag~ccct~gg 809 
. . . . . . . . . . . . . . .  t . . . .  c . t .  - . . . .  a - - - .  t . . . tga . . . t . ce  . . . . . . . . . . . .  
gt~aggctgg~agctcatg~atggaggagggggggtcccattttgaaattgagtctcccc 869 
. . . t . , . .A  . . . . .  G . . . . . . . . . . . . . . . . . . . . .  T . .A .C .~TC. .~C. .T .A . .G  
ttcca~CGGGTGAAACAGTGTGTGGGGACAGTCACCCTGGAT~GATCAAGGACC~CTC 929 
R V K Q C V G T V T L D Q I K D P L  120 
. . . . . .  T . . . .T  . . . . . . . . . . . . . . . . . .  a . - . . t c . t .g .g . .gc t . . . tg . t .g  . . . . .  
GACATCAC~GCAAT~tgagt~gcccct ta t tggtgtcaagt t - -gc taatggct tggt  989  
D I T C N E  126 
.¢ . t  . . . . .  ct  . . . .  t . t coa . . c . . . t  . . . . . . . . . . . . . . .  - .ag . . . . c . tg . . c . . .  
gtggg~aact-ccttgggagtgttacccgctgccccatccagg~cgtggaaaggccctcct 1049 
. . . .  t . . . . .  c . . . . . . . . . .  g . . . . . . . . .  t . . . . . . .  a tg . , t  . . . . . . . . . . . . . .  a 
acccc~gccct tccc tcacctcgg~cccagggctccaggtc tggctc tg tcaCcct tagg  1109 
. .a . t  . . . . .  t - .a .g  . . . . . . . .  t .a . . -  . . . . . . . . .  . . . . . .  t t t  . . . . .  c t . . t . . .  
gccgcggt tccc tcaatggggtccccccctcgtat t tg tcagaaaggcacat t t -ca~cc  1169 
. t - . t .a . t . . ta  . . . . . . . .  g . . c . .g  . . . . . .  a t . . . t .g .~a.g - .a . .g . .a t . . -  
ccaccccgaccctc tgaatcacactcCtgggtggggcccagcct tg tc tc t tc~cccaag  1229 
.g . . tgc . .g .aa . . . .ga  . . . . . . . .  a .a t  . . . . .  g . . . cc .ac . t t . .gg  . . . . . . . .  ot  
atccc--agcgggttcttcctgtgctgtcggctgagaggcagcgaccggactaatggacttg 1289 
. . . . . . . . . . . .  - . c . t  . . . . . . . . . .  t . . . . . . .  cc . .ec  . . . . . . .  g .c . t .ac . t . t .  
caggccctgctcc tggccagct t tgcggggctg~tt tgggaccctggcaagccc -cagcc  1349 
. .a  . . . . . . . . . . . .  gt tg . . c . . c  . . . . . . . . . .  tg t&gg . . . . .  a . . . . .  • . . . . . . . . .  at .  
atc tc tgggcctgagtccact ta tgtgtc tg tgggg . . . . .  ga t tccaccacgtgctccaaaggt  1409 
. . . . . . . .  t t . .gca .ac . . t  . . . . . . . . .  t . .gc .g t . . .g . t . .a t . . t t . . .g . .g . .  
cacagccagaggtggac-tggggccccaagcctcttactgtttccccattcagggattttt 1469 
.a . . .~- . . .a . t . , . .ga .c . . .S . . . . t . . .ec t t . . . t . . . - . tgag .g . t . . c . c .  
ctagtctggagggagggttcttgtcttgacccttggccaggccccacccaaaacctgttt 1529 
.a t . c t . . t  . . . .  a . . . . . .  a . . . . . . . . . . . .  CG . . . .  - . . . . . . . . . . . . . . . . . . . . . .  
c t  c t - tggtcactgat tcagGGTGT~GGA~TTTCCCTGGT~T~CCGTTCCTACGAAG 1589 
G V R R F P W W W P F L R R  140 
. . . . . . . . . .  C~C . . . . . . . . . . . . . . .  . . . . .  T , .T .G . .AA . . . .~ . . - - - . .A . .  
AC~CGGTTGCGACGGCAGGCTTTCCCTCCCCCAAATGTCCCCGGGCCCC~CC~CC 1649 
P R L R R O A r P P P N V P G P R F P P  160 
T . . -  . . . . . . . . . . . . . . . . .  . . . -  . . . . . . . . . . .  , . . . . .  A - - - . .~ . .C . . . °A . .  
CCCAAATGTCCCCG~CCCC~CCCTCCCCCAAATTTCCCCGGGCCCC~CCCTCC 1709 
P N V P G P R F P P P N F P G P R F P P  100 
- - - . . -  . . . . . . . . . . . . . .  . .A . . -  . . . . .  . . . -  . . . . .  . . . . . .  - . . . . .  • . . . .  A . -  
CCCAAAT~CCCCGGGCCCCGGTTCCCTCCCCCAAATTTCCCAG~CCCC~CCCTCC 1769 
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- - . . . .  . . . . . . . . . . . . . .  . . . . . . .  - . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  
GCC~TTTTCCCTGCaGCCGTGGTTCCCTCCGCCTCCACCT~CCGTCCCCCACCATTCGG 1829 
P I F P G P W F P P P P P F R P P P F G  220 
- - - . . . .C  . . . . . . .  C . .A .A  . . . . . . .  T . . .G .G . .T .AT . . .AT  . . . . .  TTA°~G. . .  
TCCACCAAGGTTCCCTGGTAGAC~TG~GGATTTGCA~CAACTCACCCAGA-AGGCCTT 1889 
P P R W P G R R *** 228 
. T . . .~ . .C~G.G . . . . .  ~ .A - . .T . . . .G . -  . . . .  TA . .GTTGT~.T , . .A .~CT.A .C .A  
TCGGTACATTAAAATCCCAGC~AGACCT~CATCTGCTTTG-  CCCAGGCC CGCATCT 1949 
GTCA~TA~TTC~GTGA~CC 1972 
Fig. 4. Nucleotide sequences of prophenin-2 and flPR-39 genes. The sequence of the PF-2 gene is shown in full, whereas nucleotides of the flPR-39 
gene are shown in bold lower or upper case letters above the PF-2 sequence only when they differ from PF-2. Identical residues are indicated by 
dots. Some gaps have been introduced for alignment, and are shown by dashes. Exon nucleotides are capitalized, and 5'-flanking region and intronic 
sequences are shown in lower case letters. Nucleotides are numbered according to the presumed transcription start site in PF-2, which is designated 
by the dagger symbol. Amino acid numbering is according to the pig PF-2 (clone 12) cDNA [18]. The signal peptide is indicated by underlined capital 
letters, and the polyadenylation signal (AATAAA) has also been underlined. The putative PF-2 precursor, prior to its final processing by proteolytic 
removal of the doubly underlined 18 N-terminal residues and conversion of its C-terminal amidation sequence (dotted underlining) is shown in bold 
capital letters. A TATA-Iike box and several potential binding sites (-  means negative strand) for regulatory factors are underlined and named. The 
bold numbers refer to the amino acid transcript of PF-2. Gaps (-) introduced into the PF-2 sequence for alignment purposes were not counted when 
numbering the bases. 
The 5' upstream regions of the genes contained clusters of 
potential transcriptional regulatory elements. Within 130 bp 
upstream of the transcriptional start sites of  all of  these genes 
were one NF-xb recognition site, one NFI  motif, two NF-IL6 
motifs and one IL-6 response element (IL6-RE) (Fig. 4). Similar 
binding sites are present in the promoter regions of other genes 
that participate in a variety of  immune responses [e.g. 31,32]. 
The presence of multiple upstream regulatory elements, includ- 
ing NF-lcB and NF-IL-6, has also been found in genes that 
encode inducible antimicrobial peptides in invertebrates [33-35] 
and in the gene of a bovine fl-defensin produced by respiratory 
tract epithelial cells [36]. The presence of  similar upstream reg- 
ulatory elements in the genes for cathelin-associated peptides 
suggests that their in vivo production is poised to respond to 
signals, such as cytokines, that are generated early during infec- 
tious challenges. 
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